Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
This is an update of the rapid risk assessment of severe respiratory disease associated with a novel coronavirus, in relation to three more laboratory confirmed infections reported from the UK in the past 10 days.
As of 16 February 2013, twelve laboratory confirmed cases of pneumonia caused by the novel coronavirus (novel CoV) have been reported to the World Health Organization (WHO). Six of the cases have been fatal and two others remain very ill.
ECDC has published an update of its risk assessment on the novel coronavirus, providing a number of conclusions and recommendations as well as background information:
- Of the total of these 12 cases, three recently confirmed cases have been diagnosed in the UK. The second and third cases were infected through human-to-human transmission although the exact route of transmission is still under investigation by the UK authorities. No sustained transmission or expanding clusters of infection have been identified in any country.
- Close follow-up of approximately 200 health care workers, family and other contacts of cases in Europe and the Middle-East have not yet found other demonstrated instances of human-to-human transmission.
- The most recent UK case, a relative of the other two UK cases, had only a mild disease and has recovered quickly. The Health Protection Agency (HPA) is undertaking intensive follow-up of close contacts of these three recent cases.
- ECDC supports recommendations of laboratory investigation for novel-CoV of patients with severe acute respiratory infection returning from the Arabian Peninsula and neighbouring countries as defined in the current WHO guidance.
- Health professionals engaged in receiving medical evacuated patients from the Arabian Peninsula and neighbouring countries with any infectious respiratory condition should be particularly vigilant concerning the possibility of infection with novel-CoV.
- Healthcare workers caring for patients under investigation for novel-CoV should exercise infection control measures following national or international guidance.
Rapid risk assessment: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo – fifth update
19 Jul 2019 - This is the fifth update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the potential public health impact of Ebola virus disease for EU/EEA countries and assesses the likelihood of international expansion.
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
2 Jul 2019 - In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
Rapid risk assessment: Dengue outbreak in Réunion, France, and associated risk of autochthonous outbreak in the EU/EEA
18 Jun 2019 - This update of the risk assessment ‘Dengue outbreak in Réunion, France’ published on 5 July 2018, has been triggered by the significant size of the outbreak and its expected duration, which is anticipated to overlap with high vector activity in the southern EU.